Movement Disorders

Adams, 1949, The neurological changes in the more common type types of severe liver disease, Trans Am Neurol Assoc, 74, 217 Adams, 1989, “Alcoholic” cerebellar degeneration, 837 Aisen, 1992, Peripheral mechanical loading and the mechanism of the tremor of chronic alcoholism, Arch Neurol, 49, 740, 10.1001/archneur.1992.00530310088016 Artieda, 1992, Cortical mechanisms mediating asterixis, Mov Disord, 7, 209, 10.1002/mds.870070304 Ashcroft, 1965, Recognition of amphetamine addicts, Br Med J, 1, 57, 10.1136/bmj.1.5426.57-b Ballard, 1985, Permanent human parkinsonism due to 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP): Seven cases, Neurology, 35, 949, 10.1212/WNL.35.7.949 Balldin, 1985, Changes in dopamine receptor sensitivity in humans after heavy alcohol intake, Psychopharmacology, 86, 142, 10.1007/BF00431699 Biary, 1985, Effect of alcohol on dystonia, Neurology, 35, 239, 10.1212/WNL.35.2.239 Bone, 1989, A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors, Psychopharmacology, 99, 386, 10.1007/BF00445563 Boyce, 1990, Differential effects of D1 and D2 agonists in MPTP-treated primates: Functional implications for Parkinson’s disease, Neurology, 40, 927, 10.1212/WNL.40.6.927 Brewer, 1992, Wilson disease, Medicine, 71, 139, 10.1097/00005792-199205000-00004 Brooks, 1992, Detection of preclinical Parkinson’s disease with PET, Neurology, 41, 24 Biicy, 1942, Cortical extirpation in the treatment of involuntary movement, Res Publ Assoc Res Nerv Ment Dis, 21, 551 Cardoso, 1993, Cocaine-related movement disorders, Mov Disord, 8, 175, 10.1002/mds.870080210 Carlen, 1981, Parkinsonism provoked by alcoholism, Ann Neurol, 9, 84, 10.1002/ana.410090117 Carlen, 1981, Cerebral atrophy and functional deficits in alcoholics without clinically apparent liver disease, Neurology, 31, 377, 10.1212/WNL.31.4_Part_2.377 Carlsson, 1967, Arterial noradrenaline levels after ethanol withdrawal, Lancet, 2, 889, 10.1016/S0140-6736(67)92619-0 Carrie, 1965, Finger tremor in alcoholic patients, J Neurol Neurosurg Psychiatry, 28, 529, 10.1136/jnnp.28.6.529 Choy-Kuong, 1989, Dystonia related to cocaine withdrawal: A case report and pathogenic hypothesis, Neurology, 39, 996, 10.1212/WNL.39.7.996-a Cregler, 1986, Medical complications of cocaine abuse, N Engl J Med, 315, 1495, 10.1056/NEJM198612043152327 Crossman, 1987, MPTP-Induced parkinsonism in the monkey: Neurochemical pathology, complications of treatment, and pathophysiological mechanisms, Can J Neurol Sci, 14, 428, 10.1017/S0317167100037859 Darden, 1977, Reduction of striatal dopamine release during an ethanol withdrawal syndrome, J Neurochem, 29, 1143, 10.1111/j.1471-4159.1977.tb06522.x Davis, 1979, Chronic parkinsonism secondary to intravenous injection of meperidine analogues, Psychiatr Res, 1, 249, 10.1016/0165-1781(79)90006-4 De Maio, 1978, Sulpiride and extrapyramidal syndromes in chronic heroin addiction, Neuropsychobiology, 4, 36, 10.1159/000117618 Deutch, 1990, 3-Acetylpyridine results in degeneration of the extrapyramidal and cerebellar motor systems: Loss of the dorsolateral striatal dopamine innervation, Brain Res, 527, 96, 10.1016/0006-8993(90)91065-O Dexter, 1989, Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease, J Neurochem, 52, 381, 10.1111/j.1471-4159.1989.tb09133.x Di Monte, 1991, Mitochondrial DNA and Parkinson’s disease, Neurology, 41, 38, 10.1212/WNL.41.5_Suppl_2.38 Di Monte, 1986, l-Methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) and l-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes, Biochem Biophys Res Commun, 137, 310, 10.1016/0006-291X(86)91211-8 Doty, 1992, Lack of major olfactory dysfunction in MPTP-induced parkinsonism, Ann Neurol, 32, 97, 10.1002/ana.410320116 Factor, 1988, Cocaine and Tourette’s syndrome, Ann Neurol, 23, 423, 10.1002/ana.410230431 Fahn, 1979, Posthypoxic action myoclonus: Review of the literature and report of two new cases with response to valproate and estrogen, Adv Neurol, 26, 49 Fahn, 1987, Members of the UPDRS Development Committee: Unified Parkinson’s pisease Rating Scale, 153 Fahn, 1991, Hereditary essential myoclonus in a large Norwegian family, Mov Disord, 6, 237, 10.1002/mds.870060308 Fang, 1991, Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite, Toxicol Lett, 59, 117, 10.1016/0378-4274(91)90062-B Farrel, 1991, Acute dystonic reaction to crack cocaine, Ann Emerg Med, 20, 322, 10.1016/S0196-0644(05)80951-5 Fernandez, 1992, Temporary deterioration in parkinsonian signs after modest alcohol intake, Mov Disord, 7, 284, 10.1002/mds.870070317 File, 1991, Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat, Neuropharmacology, 30, 183, 10.1016/0028-3908(91)90202-M Fornazzari, 1982, Transient choreiform dyskinesias during alcohol withdrawal, Can J Neurol Sci, 9, 89, 10.1017/S0317167100043742 Forno, 1986, Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys, Ann Neurol, 20, 449, 10.1002/ana.410200403 Fomo, 1988, An electron microscopic study of MPTP-induced inclusion bodies in an old monkey, Brain Res, 448, 150, 10.1016/0006-8993(88)91111-0 Friedlander, 1956, Characteristics of postural tremor in normal and various abnormal states, Neurology, 6, 716, 10.1212/WNL.6.10.716 Gallimberti, 1989, Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome, Lancet, 2, 787, 10.1016/S0140-6736(89)90842-8 Golbe, 1989, Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism, Mov Disord, 4, 147, 10.1002/mds.870040206 Graham, 1990, Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intracarotid infusion of MPTP in the monkey (Macaca fascicularis), Brain Res, 514, 103, 10.1016/0006-8993(90)90440-M Growdon, 1975, The effect of alcohol on essential tremor, Neurology, 28, 259, 10.1212/WNL.25.3.259 Hardie, 1988, Neuroleptic-induced Parkinson’s syndrome: Clinical features and results of treatment with levodopa, J Neurol Neurosurg Psychiatry, 51, 850, 10.1136/jnnp.51.6.850 Hart, 1904, Paralysis agitants: Some clinical observations based on the study of 219 cases seen at the clinic of Professor M. Allen Star, J Nerv Ment Dis, 31, 177, 10.1097/00005053-190403000-00004 Hegarty, 1991, Cocaine as a risk factor for acute dystonic reactions, Neurology, 41, 1670, 10.1212/WNL.41.10.1670 Herkenham, 1991, Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP: administration: An in vivo autoradiographic study, Neuroscience, 40, 133, 10.1016/0306-4522(91)90180-V Hochman, 1983, Meperidine-associated myoclonus and seizures in long-term hemo-dyalisis patients, Ann Neurol, 14, 593, 10.1002/ana.410140520 Hoehn, 1967, Parkinsonism: Onset, progression, and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Irwin, 1990, The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey, Brain Res, 531, 242, 10.1016/0006-8993(90)90780-F Jankovic, 1994, Stereotypes Johnson, 1990, Twin studies and the genetics of Parkinson’s disease, Mov Disord, 5, 187, 10.1002/mds.870050302 Kilty, 1991, Cloning and expression of a cocaine-sensitive rat dopamine transporter, Science, 254, 576, 10.1126/science.1948035 Kitayama, 1992, Parkinsonism-inducing neurotoxin MPP+: Uptake and neurotoxicity in nonneuronal COS cells expressing dopamine transporter cDNA, Ann Neurol, 32, 109, 10.1002/ana.410320120 Klawans, 1974, The effect of D-amphetamine on choreiform movement disorders, Neurology, 24, 312, 10.1212/WNL.24.4.312 Koller, 1983, Alcoholism in essential tremor, Neurology, 33, 1074, 10.1212/WNL.33.8.1074 Koller, 1985, Tremor in chronic alcoholism, Neurology, 35, 1660, 10.1212/WNL.35.11.1660 Kraus, 1985, Randomized clinical trial of atenolol in patients with alcohol withdrawal, N Engl J Med, 313, 905, 10.1056/NEJM198510103131501 Kuhar, 1991, The dopamine hypothesis of the reinforcing properties of cocaine, Trends Neurosci, 14, 299, 10.1016/0166-2236(91)90141-G Kumor, 1990, Cocaine withdrawal dystonia, Neurology, 40, 863, 10.1212/WNL.40.5.863 Kumor, 1986, Haloperidol-induced dystonia in cocaine addicts, Lancet, 2, 1341, 10.1016/S0140-6736(86)91478-9 Kyllerman, 1990, Alcohol-responsive myoclonic dystonia in a large family: Dominant inheritance and phenotypic variation, Mov Disord, 5, 270, 10.1002/mds.870050403 Lai, 1980, Effects of ethanol on central dopamine functions, Life Sci, 27, 299, 10.1016/0024-3205(80)90197-6 Lang, 1982, Alcohol and Parkinson disease, Ann Neurol, 12, 254, 10.1002/ana.410120307 1992 Langston, 1985, Parkinsonism induced by l-methyl-4-phenyl-l,2,3,6-tetra-hydropyridine(MPTP): Implications for treatment and the pathogenesis of Parkinson’s disease, Can J Neurol Sci, 11, 160, 10.1017/S0317167100046333 Langston, 1983, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561 Larsson, 1960, Essential tremor. A clinical and genetic population study, Acta Psychiatr Neurol Scand, 36, 1 Leavitt, 1964, Studies in asterixis, Arch Neurol, 10, 360, 10.1001/archneur.1964.00460160030002 LeFebvre-D’Amour, 1978, Tremor in alcoholic patients, Progress Clinical Neurophysioy, 6, 160 Lieberman, 1985, Reversible parkinsonism related to meperidine, N Engl J Med, 312, 509, 10.1056/NEJM198502213120809 Liljequist, 1978, Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration, Acta Pharmacol Toxicol, 43, 19, 10.1111/j.1600-0773.1978.tb02227.x Lou, 1991, Essential tremor: Clinical correlates in 350 patients, Neurology, 41, 234, 10.1212/WNL.41.2_Part_1.234 Lutz, 1976, Neuroleptic-induced akathisia and dystonia triggered by alcohol, JAMA, 236, 2422, 10.1001/jama.1976.03270220042034 Mann, 1992, Brain, skeletal muscle, and platelet homogenate mitochondrial function in Parkinson’s disease, Brain, 115, 333, 10.1093/brain/115.2.333 Maruritz, 1979, Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia, Brain, 102, 461, 10.1093/brain/102.3.461 McDougle, 1989, Pathophysiology of obsessive-compulsive disorder, Am J Psychiatry, 146, 1350, 10.1176/ajp.146.10.1350 McNagny, 1992, High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic, JAMA, 267, 1106, 10.1001/jama.1992.03480080076030 Merab, 1988, Acute dystonic reaction to cocaine, Am J Med, 84, 564, 10.1016/0002-9343(88)90292-6 Mesulam, 1986, Cocaine and Tourette’s syndrome, N Engl J Med, 315, 398, 10.1056/NEJM198608073150616 Meyerhoff, 1973, Gilles de la Tourette’s disease and minimal brain dysfunction: Amphetamines isomers reveal catecholamine correlates in an affected patient, Psychopharmacologia, 29, 211, 10.1007/BF00414035 Miller, 1990, Sulpiride-induced tardive dystonia, Mov Disord, 5, 83, 10.1002/mds.870050119 Miller, 1992, Drug-induced movement disorders: An overview, 5 Mitchell, 1985, Sites of the neurotoxic action of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus, Neurosci Lett, 61, 195, 10.1016/0304-3940(85)90424-0 Mullin, 1970, Choreoathetotic movement disorder in alcoholism, Br Med J, 4, 278, 10.1136/bmj.4.5730.278 Neiman, 1988, Parkinsonism and dyskinesias during ethanol withdrawal, Br J Addict, 83, 437, 10.1111/j.1360-0443.1988.tb00492.x Neiman, 1990, Movement disorders in alcoholism: A review, Neurology, 40, 741, 10.1212/WNL.40.5.741 Nicklas, 1985, Inhibition of NADH-linked oxidation in brain mitochondria by l-methyl-4-phenylpyridine, a metabolite of the neurotoxic l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine, Life Sci, 36, 2503, 10.1016/0024-3205(85)90146-8 1989, DAT ATOP: A multicenter controlled clinical trial in early Parkinson’s disease, Arch Neurol, 46, 1052, 10.1001/archneur.1989.00520460028009 1989, Effect of deprenyl on the progression of disability in early Parkinson’s disease, N Eng J Med, 321, 1364, 10.1056/NEJM198911163212004 Pascual-Leone, 1990, Cocaine associated multifocal tics, Neurology, 40, 999, 10.1212/WNL.40.6.999 Perlmutter, 1987, MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans, Neurology, 37, 1575, 10.1212/WNL.37.10.1575 Pifl, 1991, Effect of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey, Neuroscience, 44, 591, 10.1016/0306-4522(91)90080-8 Potter, 1989, Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs, Br Med J, 299, 150, 10.1136/bmj.299.6692.150 Quinn, 1988, Hereditary myoclonic dystonia, hereditary torsion dystonia, and hereditary essential myoclonus: An area of confusion, Adv Neurol, 50, 391 Rajput, 1991, Accuracy of clinical diagnosis in parkinsonism—A prospective study, Can J Neurol Sci, 18, 275, 10.1017/S0317167100031814 Ramsay, 1986, Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of l-methyl-4-pheny 1-1,2,3,6-tetrahydropyridine (MPTP), by mitochondria, J Biol Chem, 261, 7585, 10.1016/S0021-9258(19)57434-8 Randrup, 1967, Stereotyped activities produced by amphetamine in several species and man, Psychopharmacologia, 11, 300, 10.1007/BF00404607 Rautakorpi, 1983, Alcohol consumption of patients with essential tremor, Acta Neurol Scand, 68, 177, 10.1111/j.1600-0404.1983.tb05345.x Rinne, 1990, Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson’s disease, Mov Disord, 5, 55, 10.1002/mds.870050114 Rosenhamer, 1980, Slow tremor and delayed brainstem auditory evoked responses in alcoholics, Arch Neurol, 37, 293, 10.1001/archneur.1980.00500540071010 Sayre, 1989, Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), Toxicol Lett, 48, 121, 10.1016/0378-4274(89)90168-9 Schapira, 1990, Mitochondrial complex I deficiency in Parkinson’s disease, J Neurochem, 54, 823, 10.1111/j.1471-4159.1990.tb02325.x Schapira, 1990, Anatomic and disease specificity of NADH CoQ reductase (Complex I) deficiency in Parkinson’s disease, J Neurochem, 55, 2142, 10.1111/j.1471-4159.1990.tb05809.x Schroeder, 1982, High alcoholism rate in essential tremor patients, Am J Psychiatry, 139, 1471, 10.1176/ajp.139.11.1471 Scotcher, 1990, Effects of l-methyl-4-phenyl-l,2,3,6-tetrahy-dropyridine and l-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes, J Neurochem, 54, 1295, 10.1111/j.1471-4159.1990.tb01962.x Sellers, 1977, Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal, J Stud Alcohol, 38, 2096, 10.15288/jsa.1977.38.2096 Shandling, 1990, Parkinsonism in alcohol withdrawal: A follow-up study, Mov Disord, 5, 36, 10.1002/mds.870050109 Shen, 1984, Extrapyramidal symptoms associated with alcohol withdrawal, Biol Psychiatry, 19, 1037 Shimada, 1991, Cloning and expression of a cocaine-sensitive dopamine transporter complimentary DNA, Science, 254, 576, 10.1126/science.1948034 Silverskiold, 1977, A 3-second leg tremor in a cerebellar syndrome, Acta Neurol Scand, 55, 385, 10.1111/j.1600-0404.1977.tb05657.x Silverskiold, 1977, Cortical cerebellar degeneration associated with a specific disorder of standing and locomotion, Acta Neurol Scand, 55, 257, 10.1111/j.1600-0404.1977.tb05646.x Singer, 1991, Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment, Medicine, 70, 15, 10.1097/00005792-199101000-00002 Singer, 1991, Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette’s syndrome, Ann Neurol, 30, 558, 10.1002/ana.410300408 Sinton, 1989, The effectiveness of different isomers of octanol as blockers of harmaline-induced tremor, Pflügers Arch, 414, 31, 10.1007/BF00585623 Skillicorn, 1958, Presenile cerebellar ataxia in chronic alcoholics, Neurology, 5, 527, 10.1212/WNL.5.8.527 Stacy, 1993, Tardive stereotypies and other movement disorders in tardive dyskinesia, Neurology, 43, 937, 10.1212/WNL.43.5.937 Stern, 1990, MPTP-Induced parkinsonism, Progr Neurobiol, 34, 107, 10.1016/0301-0082(90)90003-Y Stern, 1985, Intellectual changes in patients with MPTP-induced parkinsonism, Neurology, 35, 1506, 10.1212/WNL.35.10.1506 Takada, 1990, Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death, Brain Res, 509, 55, 10.1016/0006-8993(90)90308-X Tetrud, 1989, The effect of deprenyl (selegyline) on the natural history of Parkinson’s disease, Science, 245, 519, 10.1126/science.2502843 Tetrud, 1992, Tremor in MPTP-induced parkinsonism, Neurology, 42, 407, 10.1212/WNL.42.2.407 Tetrud, 1989, Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), Neurology, 39, 1483, 10.1212/WNL.39.11.1483 Tieku, 1989, Ethanol and the benzodiazepine-GABA receptor-ionophore complex, Experientia, 45, 413, 10.1007/BF01952022 Torvik, 1986, The prevalence of alcoholic cerebellar atrophy: A morphometric and histological study of an autopsy material, J Neurol Sci, 75, 43, 10.1016/0022-510X(86)90049-3 Ugawa, 1989, Physiological analysis of asterixis: silent period locked averaging, J Neurol Neurosurg Psychiatry, 52, 89, 10.1136/jnnp.52.1.89 Victor, 1959, A restricted form of cerebellar cortical degeneration occuring in alcoholic patients, Arch Neurol, 1, 579, 10.1001/archneur.1959.03840060001001 Victor, 1965, The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration, Medicine, 44, 345, 10.1097/00005792-196509000-00001 Wasserman, 1980, Choreic movements induced by the use of methadone, Arch Neurol, 37, 727, 10.1001/archneur.1980.00500600075016 Weinreb, 1989, Rhythmic alternating asterixis, J Neurol Neurosurg Psychiatry, 45, 857, 10.1136/jnnp.45.9.857-a Woolverton, 1992, Neurobiology of cocaine abuse, Trends Pharmacol Sci, 13, 193, 10.1016/0165-6147(92)90063-C Young, 1986, Asterixis: One type of negative myoclonus, 137